Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: LIBRAX — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved a supplemental application for Librax (chlordiazepoxide hydrochloride and clidinium bromide) from Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LIBRAX (Chlordiazepoxide hydrochloride and clidinium bromide)

Snippet

SUPPL AP for LIBRAX (CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE)